Every state, kept current
The Rates plan
$29/mo7-day free trialThis page shows one representative rate per state for Q2050. Full schedules include every locality, modifier, and age-band variant.
- Every code on all 51 published schedules
- Full-schedule CSV export and state network lists
- Email alerts when a state changes its rates
$29/mo after the trial. Cancel anytime.
Publishing states
31
Median % of Medicare
--
Rate range
$10.87 - $3,513.48
Q2050 rates in every publishing state
| State | Medicaid rate | % of Medicare | Prior auth | Vintage |
|---|---|---|---|---|
| Alabama | $108.47 | -- | -- | 2026 |
| Arkansas | $3,513.48 | -- | -- | 2026 |
| Arizona | $129.25 | -- | -- | 2026 |
| California | $71.86 | -- | -- | 2026 |
| Connecticut | $136.05 | -- | -- | 2025 |
| District of Columbia | $104.01 | -- | Required | 2026 |
| Iowa | $342.92 | -- | -- | 2024 |
| Idaho | $89.87 | -- | Not required | 2026 |
| Illinois | $69.92 | -- | -- | 2026 |
| Indiana | $168.08 | -- | -- | 2024 |
| Kansas | $116.61 | -- | -- | 2026 |
| Kentucky | $104.01 | -- | -- | 2026 |
| Maine | $116.61 | -- | -- | 2026 |
| Michigan | $116.61 | -- | -- | 2026 |
| Minnesota | $116.60 | -- | -- | 2026 |
| Mississippi | $71.86 | -- | -- | 2026 |
| Montana | $104.01 | -- | -- | 2026 |
| Nebraska | $116.60 | -- | -- | 2026 |
| New Hampshire | $10.87 | -- | Not required | 2026 |
| New Jersey | $533.56 | -- | Not required | 2026 |
| New Mexico | $136.05 | -- | -- | 2025 |
| Oklahoma | $116.61 | -- | -- | 2026 |
| Rhode Island | $521.01 | -- | -- | 2026 |
| South Carolina | $116.61 | -- | -- | 2026 |
| Texas | $109.28* | -- | -- | 2026 |
| Utah | $116.61* | -- | Not required | 2026 |
| Virginia | $116.60 | -- | -- | 2026 |
| Vermont | $103.05 | -- | -- | 2026 |
| Washington | $116.61 | -- | -- | 2026 |
| Wisconsin | $116.61 | -- | -- | 2026 |
| Wyoming | $116.61 | -- | -- | 2026 |
Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.
Related state-specific services codes
- C1716 - Brachytherapy source, non-stranded, gold-198, per source
- C1717 - Brachytherapy source, non-stranded, high dose rate iridium-192, per source
- C1719 - Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source
- C2616 - Brachytherapy source, non-stranded, yttrium-90, per source
- C2634 - Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source
- C2635 - Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source
- C2636 - Brachytherapy linear source, non-stranded, palladium-103, per 1 mm
- C2638 - Brachytherapy source, stranded, iodine-125, per source
All 12 codes from Q2009 to Q2058 or every state-specific services code by number.
Frequently asked questions
How much does Medicaid pay for Q2050?
31 state Medicaid programs publish a fee-for-service rate for Q2050 (injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg), ranging from $10.87 in New Hampshire to $3,513.48 in Arkansas. The full table on this page lists every publishing state's current rate.
Which state pays the most for Q2050?
Arkansas publishes the highest Medicaid rate for Q2050 at $3,513.48. New Hampshire publishes the lowest at $10.87.
Does Q2050 require prior authorization under Medicaid?
1 of the 31 publishing states flag Q2050 as requiring prior authorization (always or conditionally) on their fee schedules. States without a flag publish no PA indicator for this code - that means "not published", not "no PA required".